Case study
|
July 17, 2025
PCC Selection to IND Submission for a PROTAC Drug Candidate
Discover how BioDuro' s integrated expertise propelled a complex targeted protein degrader toward clinical trials. This case study showcases our cross-functional approach to overcoming unique PROTAC development challenges—delivering speed, scalability, and compliance critical for IND success.
Key Highlights
- Seamless Collaboration: Unified chemistry, API, drug product, and regulatory teams
- Efficiency Milestone: Advanced from PCC to IND in 12 months
- Innovative Solutions: Novel purification & process design for 98% purity
- Risk Mitigation: Overcame inherent technical complexities & secured material supply
Download the full case study to explore how BioDuro accelerates high-potential PROTACs from lab to clinic.
